As the connection between DM and HF still remains incompletely understood, in this review article, we aim to provide an overview of the most recent evidence in the epidemiology and pathophysiology as well as the role of sodium-glucose cotransporter-2 inhibitors (SGLT2i) in the management of this deleterious interaction. The gene discussed is SLC5A2; the disease is hydrops fetalis.